Evidence map›Paper›PMID 38136742›Full record

ArticleAntibiotics (Basel, Switzerland)2023

The Identification of a Novel Spider Toxin Peptide, Lycotoxin-Pa2a, with Antibacterial and Anti-Inflammatory Activities.

Min Kyoung Shin, In-Wook Hwang, Bo-Young Jang, Kyung-Bin Bu, Dong-Hee Han, Seung-Ho Lee, Jin Wook Oh, Jung Sun Yoo, Jung-Suk Sung

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Min Kyoung ShinDepartment of Life Science, Dongguk University-Seoul, Goyang 10326, Republic of Korea.
In-Wook HwangDepartment of Life Science, Dongguk University-Seoul, Goyang 10326, Republic of Korea.
Bo-Young JangDepartment of Life Science, Dongguk University-Seoul, Goyang 10326, Republic of Korea.
Kyung-Bin BuDepartment of Life Science, Dongguk University-Seoul, Goyang 10326, Republic of Korea.
Dong-Hee HanDepartment of Life Science, Dongguk University-Seoul, Goyang 10326, Republic of Korea.
Seung-Ho LeeDepartment of Life Science, Dongguk University-Seoul, Goyang 10326, Republic of Korea.
Jin Wook OhDepartment of Life Science, Dongguk University-Seoul, Goyang 10326, Republic of Korea.
Jung Sun YooSpecies Diversity Research Division, National Institute of Biological Resources, Incheon 22689, Republic of Korea.
Jung-Suk SungDepartment of Life Science, Dongguk University-Seoul, Goyang 10326, Republic of Korea.ORCID 0000-0002-3145-8458
Dongguk University · KRNational Institute of Biological Resources · KR

Funding

National Institute of Biological Resources NIBR202304103National Institute of Biological Resources NIBR202333202
6 · The paper itself

Abstract

With the increasing challenge of controlling infectious diseases due to the emergence of antibiotic-resistant strains, the importance of discovering new antimicrobial agents is rapidly increasing. Animal venoms contain a variety of functional peptides, making them a promising platform for pharmaceutical development. In this study, a novel toxin peptide with antibacterial and anti-inflammatory activities was discovered from the spider venom gland transcriptome by implementing computational approaches. Lycotoxin-Pa2a (Lytx-Pa2a) showed homology to known-spider toxin, where functional prediction indicated the potential of both antibacterial and anti-inflammatory peptides without hemolytic activity. The colony-forming assay and minimum inhibitory concentration test showed that Lytx-Pa2a exhibited comparable or stronger antibacterial activity against pathogenic strains than melittin. Following mechanistic studies revealed that Lytx-Pa2a disrupts both cytoplasmic and outer membranes of bacteria while simultaneously inducing the accumulation of reactive oxygen species. The peptide exerted no significant toxicity when treated to human primary cells, murine macrophages, and bovine red blood cells. Moreover, Lytx-Pa2a alleviated lipopolysaccharide-induced inflammation in mouse macrophages by suppressing the expression of inflammatory mediators. These findings not only suggested that Lytx-Pa2a with dual activity can be utilized as a new antimicrobial agent for infectious diseases but also demonstrated the implementation of in silico methods for discovering a novel functional peptide, which may enhance the future utilization of biological resources.

Indexed as

anti-inflammatory activityantimicrobial activityin silico analysisspider toxin peptidespider venom transcriptome

Identifiers

PMID38136742
PMCPMC10740532
OpenAlexW4389454182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.